CrossrefInfokarte
Characterization of the Cross-Resistance of SARS-CoV-2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir
ACS Pharmacology & Translational Science · 2026-02-13 · 9 (2) · 404-413
DOI: 10.1021/acsptsci.5c00681 ↗Abstract
Kein Abstract verfügbar.
EUVIMED